Medical weight loss in Chicago

Cook County numbers behind the demand

About 2,731,585 people lived in Chicago on July 1, 2025 ^[5]. Across Cook County, CDC PLACES estimates 31.0% of adults had obesity in 2023 and 11.8% had a diabetes diagnosis ^[4]. Those are the groups weight drugs are labeled for: Zepbound is approved for adults with obesity, or with overweight plus a weight-related condition ^[6].

Coverage is the sticking point. Lilly, quoting an IFEBP survey, says roughly half of Americans with job-based insurance have no benefit for obesity drugs ^[7]. New to all this? Start with the weight loss guide.

That listing is paid placement. We label it, and it is not a recommendation. See how we make money.

Three routes to a Chicago prescription

• Your own primary care doctor or an endocrinologist. Often cheapest when your plan pays for visits, even if the drug is still self-pay.
• A storefront weight clinic. Fees are rarely posted. Ask whether the monthly charge buys visits, labs, the drug, or only the prescription.
• Telehealth. A prescriber with an Illinois license sees you by video or form and sends the order to a pharmacy. Compare programs on online GLP-1 programs.

Northwestern Medicine, Rush University System for Health and UChicago Medicine are the city's big academic systems. None of them posts a weight management price list that we found, so call primary care or endocrinology and ask. Questions to bring are in our clinic finder checklist. Drug-specific local pages: tirzepatide in Chicago and semaglutide in Chicago.

The drug's price, before a clinic adds anything

Wegovy tablets start at $149 for 1.5 mg, then $199 at 4 mg and $299 at 9 or 25 mg; Wegovy pens are $349 for any dose from 0.25 to 2.4 mg ^[3]. Zepbound is $299 to $449 at LillyDirect, more if a refill runs late ^[2], against a $1,087 list price ^[9]. Foundayo, Lilly's tablet, is $149 to $299 ^[8]. A Chicago clinic quoting one flat monthly figure is either folding its fee into one of these prices or selling a compounded drug. Ask which, and read compounded tirzepatide if it is the second. Full detail: GLP-1 cost guide.

Illinois coverage: Medicaid, Medicare and job-based plans

KFF's January 2026 list of 13 states paying for obesity GLP-1s through Medicaid leaves Illinois out ^[1]. Members with type 2 diabetes are a separate case, since Ozempic and Mounjaro are diabetes drugs. For Chicagoans on Part D, the temporary Medicare GLP-1 Bridge runs July 1, 2026 to December 31, 2027 at a $50 monthly copay for those who qualify ^{[10] [11]}; see our Medicare GLP-1 page. A worker whose plan already covers Zepbound may pay as little as $25 with Lilly's savings card ^[12].

Checking a clinic before you pay

1. Search the prescriber in the Illinois Department of Financial and Professional Regulation license lookup ^[13].
2. Know the state rule: the Illinois Medical Practice Act bars licensees from sharing fees with others in return for referrals, apart from listed arrangements ^[18]. Referral bonuses are a warning sign.
3. Look the company up in our FDA warning letter tracker. In a single wave announced March 3, 2026, FDA warned 30 telehealth firms ^[14].
4. Ask for the pharmacy's name and whether the product is brand or compounded.
5. Get refund and cancellation terms in writing before the first charge.

Neighboring guides: Indianapolis, Detroit, Minneapolis and St. Louis, where Missouri's Medicaid rules differ from Illinois.

Safety points from the labels

Elsewhere in the Upper Midwest, our Minneapolis weight loss guide covers Minnesota's Medicaid and board rules.